PortViewPortView
Qilian International Holding logo

Qilian International Holding (QLI) Stock Analysis

NASDAQHealthcareDrug Manufacturers - Specialty & Generic

$5.41-3.57%
1-year price historyRange $0.77 – $8.31
52-week range$5.41
$1.78$6.69

What Qilian International Holding does

Qilian International Holding Group Limited (QLI), founded in 2019 and headquartered in Jiuquan, People's Republic of China, focuses on the research, development, and production of active pharmaceutical ingredients (APIs), traditional Chinese medicine derivatives (TCMDs), and a variety of other products. The company's diverse offerings include licorice-derived products such as Gan Di Xin, an antitussive and expectorant medicine; Qilian Shan Licorice Extract, supplied to pharmaceutical companies for manufacturing traditional licorice tablets; and Qilian Shan licorice liquid extract, a key ingredient for producing compound licorice oral solutions. QLI also produces Qilian Shan oxytetracycline tablets, used to prevent and treat a range of diseases in chickens, turkeys, cattle, swine, and humans, alongside Qilian Shan oxytetracycline APIs for other pharmaceutical manufacturers. Its TCMD line features Ahan antibacterial paste, designed for addressing stubborn chronic skin ailments. Furthermore, the company provides heparin sodium preparations to pharmaceutical firms for developing medications related to cardiovascular diseases, cerebrovascular conditions, and hemodialysis. Beyond the medical sector, Qilian International offers Zhu Xiaochang natural sausage casings for culinary applications. In agriculture, it produces Xiongguan organic fertilizers, formulated to improve crop yield, enhance soil chemical properties, and reduce compaction, as well as Xiongguan organic-inorganic compound fertilizers to stimulate plant growth.

Key metrics

Market cap
$38.68M
P/E (TTM)
-4.92
EPS (TTM)
$-1.10
Beta
1.41
Dividend yield
0.00%
Revenue / share
$1.30
50-day avg
$5.10
200-day avg
$3.57
52-week high
$6.69
52-week low
$1.78
CEO
Chen Xin

ETFs linked to QLI

Broad-market and Healthcare sector ETFs an investor holding Qilian International Holding is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how QLI fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze QLI in PortView →

Similar companies

Frequently asked questions

What is the ticker symbol for Qilian International Holding?
Qilian International Holding trades under the ticker QLI on NASDAQ.
Which exchange is QLI listed on?
QLI is listed on NASDAQ.
What sector does Qilian International Holding operate in?
Qilian International Holding is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).
How can PortView help analyze QLI in a portfolio?
PortView shows QLI's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.